SPC
RGNX icon

Sigma Planning Corp’s Regenxbio RGNX Stock Holding History

Sigma Planning Corp’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-35,860
Closed -$256K – 1326
2025
Q1 		$256K Sell
35,860
-1,450
-4% -$10.8K 0.01% 1026
2024
Q4 		$288K Sell
37,310
-900
-2% -$8.45K 0.01% 944
2024
Q3 		$401K Buy
38,210
+5,701
+18% +$69.5K 0.01% 826
2024
Q2 		$380K Buy
32,509
+4,934
+18% +$76.8K 0.01% 834
2024
Q1 		$581K Buy
27,575
+15,145
+122% +$269K 0.02% 706
2023
Q4 		$223K Sell
12,430
-22,011
-64% -$388K 0.02% 740
2023
Q3 		$567K Sell
34,441
-15
-0% -$272 0.02% 653
2023
Q2 		$689K Buy
34,456
+4,610
+15% +$88.8K 0.02% 606
2023
Q1 		$564K Buy
29,846
+7,175
+32% +$159K 0.02% 748
2022
Q4 		$514K Sell
22,671
-107
-0.5% -$2.42K 0.02% 753
2022
Q3 		$602K Sell
22,778
-2,070
-8% -$61.4K 0.02% 661
2022
Q2 		$614K Buy
24,848
+177
+0.7% +$4.42K 0.02% 675
2022
Q1 		$819K Sell
24,671
-25
-0.1% -$694 0.02% 624
2021
Q4 		$808K Sell
24,696
-117
-0.5% -$3.98K 0.02% 632
2021
Q3 		$1.04M Buy
24,813
+906
+4% +$32.6K 0.03% 527
2021
Q2 		$929K Buy
23,907
+142
+0.6% +$5.08K 0.03% 582
2021
Q1 		$811K Buy
+23,765
New +$1.01M 0.03% 581
2018
Q3 		– Sell
-3,180
Closed -$228K – 989
2018
Q2 		$228K Buy
+3,180
New +$152K 0.02% 776

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Sigma Planning Corp's RGNX Position: Q2 2025 in Review

Sigma Planning Corp sold out of Regenxbio (RGNX) in Q2 2025, closing a stake of 35,860 shares — an estimated $256K sold.

Sigma Planning Corp first reported a position in RGNX in Q2 2018 and held it in 18 quarters. The position peaked at $1.04M in Q3 2021. 159 funds tracked by Wall St. Rank hold RGNX as of Q2 2025.

  • Sigma Planning Corp reported no remaining Regenxbio position as of Q2 2025 after selling out during the quarter.
  • Sigma Planning Corp sold 35,860 Regenxbio shares in Q2 2025, an estimated $256K.
  • Sigma Planning Corp first reported a position in Regenxbio in Q2 2018 and held it in 18 quarters.
  • Sigma Planning Corp's Regenxbio position peaked at $1.04M in Q3 2021.
  • 159 funds tracked by Wall St. Rank held Regenxbio as of Q2 2025.

Based on Sigma Planning Corp's 13F filing for Q2 2025, filed 5 Aug 2025.